Navigation Links
SARcode Bioscience Completes $44 Million Series B Financing
Date:7/18/2011

dry eye and diabetic macular edema. LFA-1 is member of the integrin family of adhesion receptors found on the surface of all leukocytes and represents a therapeutic target central to a number of inflammatory stimuli. SAR 1118 has demonstrated potency in blocking LFA-1 binding to its cognate ligand, intercellular adhesion molecule-1 (ICAM-1; CD54), thereby inhibiting cell adhesion, cytokine production, and cellular proliferation in in vitro models. In a Phase 2 trial, SAR 1118 demonstrated dose-dependent improvements in both signs and symptoms of dry eye.

About SARcode Bioscience

SARcode Bioscience, Inc., founded in 2006, is a venture-backed ophthalmic biopharmaceutical company based in Brisbane, CA.  SARcode's lead development program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases.  Institutional investors include Alta Partners, Clarus Venture Partners, Rho Ventures and Sofinnova Ventures. www.sarcode.com.

About Sofinnova Ventures

Sofinnova Ventures has over 30 years of experience building life science corporate spin-outs and start-ups into market leaders. With $1 billion under management, the firm applies capital and expertise to guide companies to successful exits. Sofinnova's team of MDs and PhDs has significant scientific, operational and strategic experience, specializing in financing later stage clinical compounds. Sofinnova has offices in Menlo Park and La Jolla, California. www.sofinnova.com.

About Rho Ventures

Rho Ventures has a multi-stage investing strategy focused on high-growth companies in large markets. Rho Ventures' investments span new media, healthcare, IT, communications, energy technology and other disruptive technologies. Rho Ventures brings nearly 30 years of venture experience, combin
'/>"/>

SOURCE SARcode Bioscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
2. SARcode Corporation Announces Phase 2 Study Results of SAR 1118 Topical Ophthalmic Solution for the Treatment of Dry Eye
3. Quinton Oswald Named Chief Executive Officer of SARcode Corporation
4. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
10. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
11. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SUNNYVALE, Calif., July 31, 2014 Pharmacyclics, Inc. (the ... and recent developments for the quarter ended June 30, 2014. ... Ended June 30, 2014 Revenue Total revenue for the ... $54.7 million for the quarter ended June 30, 2013 primarily ... $109.5 million. Total revenue for the six ...
(Date:7/31/2014)... Conn. , July 31, 2014  UBM Medica ... a leading online community for oncologists, presents exclusive slide ... that are essential to quality cancer care. ... journal ONCOLOGY , offers news, blogs, and podcasts ... for oncologists highlighting quality cancer care: , End-of-life ...
(Date:7/31/2014)... , July 31, 2014 Touro University California,s ... been selected as the recipient of a $150,000 grant ... allow the University to increase research and classroom space ... state-of-the-art technology for the study of health sciences, and ... diverse needs and interests of our students," said ...
Breaking Medicine Technology:Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24Pharmacyclics Reports Second Quarter 2014 Results 25Pharmacyclics Reports Second Quarter 2014 Results 26Pharmacyclics Reports Second Quarter 2014 Results 27Pharmacyclics Reports Second Quarter 2014 Results 28Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Touro University California Garners Grant From Long Foundation 2
... June 21 In a head-to-head, Phase III ... System versus tobramycin inhalation solution in cystic fibrosis patients ... non-inferiority for mean percent change in forced expiratory volume ... of treatment was achieved.  Patients receiving Cayston had a ...
... 21, 2010 The Pharmaceuticals practice at,MarketsandMarkets is pleased to announce a new ... , , ... Confectionery Market (2010,-2015) Market Report. Early buyers will receive 10% customization of reports, http://www.marketsandmarkets.com/Market-Reports/diet-food-247.html ... The global diet ...
Cached Medicine Technology:PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 2PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 3PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 4World Diet Food and Confectionery Market (2010 -2015): MarketsandMarkets 2World Diet Food and Confectionery Market (2010 -2015): MarketsandMarkets 3World Diet Food and Confectionery Market (2010 -2015): MarketsandMarkets 4
(Date:7/31/2014)... (PRWEB) July 31, 2014 According to ... Business Journal , Endo International, one of several manufacturing ... thousands of transvaginal claims for $830 million (in re: ... Litigation (MDL No. 2325). Melinda Helbock, Founder of The ... agrees with the settlement and is pleased to see ...
(Date:7/31/2014)... today in Genes & Development , Dr ... DNA Replication group, in collaboration with Brookhaven National ... involved in the enzyme that governs DNA duplication ... using synthetic, chemical and structural biology approaches, the ... duplicating genetic information embraces DNA through a gated ...
(Date:7/31/2014)... July 31, 2014 Rich Dad® Education ... yard sale to benefit Habitat for Humanity. The yard sale ... raised with 100% of the proceeds donated to Habitat for ... not sold at the event were donated to the Habitat ... North Fort Myers, Florida 33903. , Of the over ...
(Date:7/31/2014)... Transplant surgeons often feel emotionally drained and overextended, ... study suggests. Nearly half of the transplant ... sense of personal accomplishment and four out of ... "Burnout is common in medicine, especially in ... Abouljoud, director of the Henry Ford Transplant Institute, ...
(Date:7/31/2014)... BUFFALO, N.Y. Athletes and others reporting cognitive difficulties ... had a concussion. But is it really a concussion? ... faculty finds that many of the same symptoms are ... and/or balance system, known collectively as cervical/vestibular injuries. , ... 128 patients some of whom were professional athletes ...
Breaking Medicine News(10 mins):Health News:San Diego Product Liability Firm Provides Commentary on the Latest Developments in Transvaginal Mesh Litigation 2Health News:Molecular gate that could keep cancer cells locked up 2Health News:Rich Dad Education Charity Yard Sale to Benefit Habitat for Humanity of Lee and Hendry Counties a Success 2Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2Health News:Is it really a concussion? Symptoms overlap with neck injuries so diagnosis is tough call 2Health News:Is it really a concussion? Symptoms overlap with neck injuries so diagnosis is tough call 3
... Ga., Sept. 19 Dominium Benefits, LLC,continues its ... its team. "We are very excited to include ... further our ability to provide,successful results for our ... Benefits, LLC, the next generation employee benefits brokerage,and ...
... four people in westernized countries experience pain or discomfort ... to offer except anti-acid medicines, which usually dont work. ... found evidence that an abnormal amount of inflammatory cells ... a fresh way of understanding the common complaint. , ...
... 19 Billian,s HealthDATA, the industry,s,only end-to-end resource ... they have recently completed the updates to their ... addition to the updated,information about the facilities and ... increase in the number of overall contacts compared ...
... Sept. 19 Former Speaker of the,House and founder ... a group of conservative Republican lawmakers on Capitol Hill,today ... in the,Congress over the State Children,s Health Insurance Program ... he was insistent that Congress,not lose sight of the ...
... BOSTON, Sept. 19 The United States District,Court ... approval of,two Proposed Settlements on behalf of a ... drugs. Plaintiffs filed the lawsuits, New,England Carpenters Health ... D.C. 37 Health & Security Plan v. Medi-Span, ...
... First and Only Nasal Spray Influenza Vaccine for Young Children in ... Available for 2007-2008 ... that the U.S. Food and Drug Administration (FDA) has approved the,expanded ... five years of age. FluMist is now approved for active,immunization for ...
Cached Medicine News:Health News:Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction 2Health News:Billian's HealthDATA Completes Comprehensive Long Term Care Database Update 2Health News:Center for Health Transformation Founder Newt Gingrich Calls on Congress to Pass a 'Clean' SCHIP Six-Month Extension 2Health News:Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals 2Health News:Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals 3Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 2Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 3Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 4Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 5
... Independent controls for Digital ... stainless steel front. Anodized aluminum ends. ... stainless steel floor. , Oversized refrigeration ... 10C , Positive seal self-closing doors. ...
... The F340 is a basic laboratory ... compensated pH results can be obtained when ... a 3-in-1 electrode. • Fast and easy ... buffer recognition for five buffers (pH 1.68, ...
... The F340 is a basic laboratory ... compensated pH results can be obtained when ... a 3-in-1 electrode. • Fast and easy ... buffer recognition for five buffers (pH 1.68, ...
... dual-monochromator, multi-detection microplate reader with a ... reading capability. Detection modalities include absorbance ... and have optical performance comparable to ... Endpoint, kinetic, spectrum and area-well scanning ...
Medicine Products: